ImmunityBio (IBRX) Gross Profit (2023 - 2026)
ImmunityBio (IBRX) reported Gross Profit of $50.94 million for Q2 2026, up 93.8% from $26.29 million a year earlier and up 15.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Gross Profit (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ImmunityBio's Gross Profit came in at $164.7 million, up 192.0% year-over-year; for FY2025, it was $112.54 million, up 663.2% from FY2024.
- Gross Profit has a three-year compound annual growth rate of 676.9% (FY2022 to FY2025).
- By year, Gross Profit came in at $14.75 million in FY2024, $622,000 in FY2023 (+159.2%) and $240,000 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Gross Profit in data going back to Q2 2023.
- Year over year, Gross Profit has now increased in each of the last four quarters, with growth averaging 271.2% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $43.97 million (Q1 2026), $37.9 million (Q4 2025) and $31.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | ImmunityBio | 7.48 Bn | 6.24 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.94 Mn |
| Mar 31, 2026 | 43.97 Mn |
| Dec 31, 2025 | 37.90 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | 26.29 Mn |
| Mar 31, 2025 | 16.46 Mn |
| Dec 31, 2024 | 7.55 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 41,000.00 |
API Access
ImmunityBio Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();